Cargando…

Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option

Detalles Bibliográficos
Autores principales: Cui, Shuhui, Tobe, Ruoyan Gai, Mo, Xiuting, Liu, Xiaoyan, Xu, Lingzhong, Li, Shixue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161355/
https://www.ncbi.nlm.nih.gov/pubmed/30261847
http://dx.doi.org/10.1186/s12879-018-3370-8
_version_ 1783358970690273280
author Cui, Shuhui
Tobe, Ruoyan Gai
Mo, Xiuting
Liu, Xiaoyan
Xu, Lingzhong
Li, Shixue
author_facet Cui, Shuhui
Tobe, Ruoyan Gai
Mo, Xiuting
Liu, Xiaoyan
Xu, Lingzhong
Li, Shixue
author_sort Cui, Shuhui
collection PubMed
description
format Online
Article
Text
id pubmed-6161355
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61613552018-10-01 Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option Cui, Shuhui Tobe, Ruoyan Gai Mo, Xiuting Liu, Xiaoyan Xu, Lingzhong Li, Shixue BMC Infect Dis Correction BioMed Central 2018-09-27 /pmc/articles/PMC6161355/ /pubmed/30261847 http://dx.doi.org/10.1186/s12879-018-3370-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Cui, Shuhui
Tobe, Ruoyan Gai
Mo, Xiuting
Liu, Xiaoyan
Xu, Lingzhong
Li, Shixue
Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option
title Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option
title_full Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option
title_fullStr Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option
title_full_unstemmed Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option
title_short Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option
title_sort correction to: cost-effectiveness analysis of rotavirus vaccination in china: projected possibility of scale-up from the current domestic option
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161355/
https://www.ncbi.nlm.nih.gov/pubmed/30261847
http://dx.doi.org/10.1186/s12879-018-3370-8
work_keys_str_mv AT cuishuhui correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption
AT toberuoyangai correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption
AT moxiuting correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption
AT liuxiaoyan correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption
AT xulingzhong correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption
AT lishixue correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption